53 results about "Pain medication" patented technology

A surgical fastening system, utilizing surgical clips made from bio-absorbable materials, for use in the rapid closing of deep internal wounds in humans or animals is disclosed. Elements of the system include surgical clips, applicators of surgical clips and dispensers of surgical clips. The surgical clips may contain small amounts of prophylactic antibiotic medication, long-acting time-release pain medication, radio-opaque markers, small amounts of radioactive material, colors, and/or patterns.

This patent is an evolution of previous combination medication patents. Previous combination patents such as U.S. Pat. No. 6,613,354 which is a combination of an NSAID and Proton Pump Inhibitor. Thus the previous patents have covered gastrointestinal prophylaxis but none has covered both gastrointestinal and cardiovascular prophylaxis. This is likely because the cardiovascular side effects of NSAIDs were only recently discovered. This patent thus represents a leap in safety in a class of medication that is used by millions of Americans on a daily basis. This combination would thus decrease morbidity and mortality.

The method of reducing pain in a patient by combining a traditional pharmacological treatment with electro-acupuncture or percutaneous electrical nerve stimulation therapy. The pharmacological treatment consists of using analgesics such as morphine sulfate and hydromorphine provided to patients around the clock or as needed for pain. The patient controlled analgesia pump (PCA) is used by patients for self-administering of analgesia as needed. After patient stops using PCA pump narcotic and non-narcotic pain medications are administered mostly orally. Typically, there are two pairs of needle electrodes, two on each leg, connected to two separate outputs of the portable electrical stimulator. The constructions of the needle holder and the stimulator allow a patient to move freely and, if necessary, to carry the device during the entire day.

The invention is a postoperative binder and method of use. The binder is made of relatively inelastic material that is cut to fit the patient and held in place by a plurality of tails fastened with Velcro(R) binders. The present invention uses mechanical, rather than elastic, compression. Mechanical loads are carried over the iliac crest, by hooking the tails of the binder over the iliac crest and then bifurcating the tails for attachment to the abdominal portion of the binder. The present invention provides support of lower abdominal tissue, especially near the genitals and in the area of the peritoneum. The invention is also a method of preventing post-operative wound infection, reducing incidence of seroma and hematoma formation and wound separation while reducing pain and the need for pain medication by passing a relatively inelastic abdominal binder over the patient's iliac crest and abdomen to place the binder in tension so as to provide a greater than 180 degree radius of compression to the wound.

Disclosed are analgesic-related compositions and methods of using the compositions for modulation of analgesic receptor activity. The compositions and methods are useful for reducing pain, as well as for therapeutic intervention of addictions or other diseases or disorders amenable to treatment or prophylaxis by modulation of analgesic receptor signaling.

A protein gel for encapsulation and controlled delivery of bioactive compounds is provided. These specific bioactive compounds may include but are not limited to vitamins, minerals, medications, probiotics and other bioactive supplements; and the amounts and/or dosages of the bioactive agents and ingredients may be adjusted to properly suit adults, children, or elderly dependent upon the end-use. This protein gel may act as both a pharmaceutical and nutraceutical, and may contain the active therapeutic compound, such as an antibiotic, chemotherapeutic, or pain medication in conjunction with specific nutrients that may act synergistically with the medication to enhance efficacy and overall health of the patient. The gel may be consumed alone or incorporated into food products such as cereal-type bars or mixed into biscuits, cookies, and the like.

A supplemental pain medication device may be placed in parallel with a basal rate controller for providing a temporary increased level of pain medication to a patient on demand. a trigger of the supplemental pain medication device must be initially depressed in order to allow fluid to flow through the device so that an upper body of the device which is attached to a plunger may slide into a lower body which is attached to a reservoir. When the upper body is slid into the lower body, the plunger also slides into the reservoir to pump fluidic pain medication out of the device.

A kind of medicine for treating heel pain, which is decocting Angelica, Chuanxiong, Frankincense, Myrrh, Ligustrum lucidum, Cuscuta, Dipsacus, Earthworm, Achyranthes achyranthes, Gentiana, scallion, and Artemisia argyi leaves with water to obtain a decoction, concentrated Then add conventional auxiliary materials, add purified water until the crude drug content is 1g/mL, fill and sterilize to make an oral liquid preparation. The medicine of the present invention promotes blood circulation and removes blood stasis, dispels wind and relieves pain, and has quick effect on treating heel pain, and makes the pain disappear quickly, and has the effect of treating both symptoms and root causes. The medicine of the present invention has a high cure rate, no recurrence, no sequelae, and the patient has no pain during the treatment , the effective rate is 100% through clinical observation.

Analgesic formulations to be applied topically that are reported to relieve moderate to severe pain due to tendonitis, fibromyalgia, shingles, insect bites and bee stings, ACL, arthritis, and sinus headaches. In many cases, test subjects report immediate pain relief with a single application and complete pain elimination with only a few applications. The formulations are in a coconut oil base which is skin friendly. The primary active ingredient is wrightia tinctoria, which when combined with other ingredients, causes the formulation to exhibit a synergistic effect on pain relief unexpected from using the ingredients alone or in combination.

A pump system for pain management may receive input related to a patient's real-time pain to provide automatic adjustments of pain medication bolus delivery based on deduced patient pain. The pump may also collect pain management information during the delivery of pain medication to provide data for improved pain management protocols.

A handheld pain reliever includes a hollow handle, a presser bar having an end piece extended from a rear end of a connection rod thereof inserted into the handle and a presser ring provided with protruding portions connected to a front end of the connection rod at an angle, a vibrator mounted inside the handle for vibrating the presser bar, a rechargeable battery mounted inside the handle adjacent to provide the necessary working voltage to the vibrator, and an on/off switch mounted at the handle and operable to switch on/off the vibrator.

The invention provides a soluble absorbable hemostasis product based on modified novamat and a preparing method. The method includes steps as follows: preparing gasohol solution with concentration of 60-95%, then adding into sodium hydroxide solution, increasing temperature to 10-85 degrees Celsius, stirring well, adding into novamat, processing dynamic chemical combination within 0.5-12 hours in condition of stirring or supersonic vibrating, then taking out and obtaining a modified novamat semi-finished product, adding chloroacetic acid solution into the medical solution as above continuously, putting the semi-finished product into the medical solution, processing dynamic chemical combination within 0.5-12 hours under 10-85 degree Celsius continuously, taking out, (or adding or not adding antibacterial agent and pain medication lt; antibacterial agent is ciprofloxacin, povidone iodine or the compound; pain medication is benzocaine, lidocaine or the compound gt), adjusting PH value and drying.

A method for the detection and quantitation of pain medication in oral fluid specimens is provided. First, a Solid Phase Extraction (“SPE”) process is used to isolate cocaine and its metabolite, amphetamines and/or butalbital from human oral fluid samples. Alternatively, Liquid-Liquid Extraction (“LLE”) is used to isolate methadone and its metabolite, fentanyl and norfentanyl, buprenorphine and norbuprenorphine, propoxyphene and norpropoxyphene, carisoprodol, meprobamate, a series of benzodiazepines, tramadol and its metabolites, the analgesic opioids, and tetrahydrocannabinol (“THC”) and its carboxylated metabolite (“THC-C”). Finally, following isolation of these drugs and their metabolites, they are separated respectively using a high performance liquid chromatographic column and a novel combination chromatographic solvents and gradients. All analytes are detected and quantified using a tandem mass spectrometry (“MS/MS”) precursor to produce ion transitions.

Disclosed herein are compositions and methods for treating post-surgical pain in a patient in need thereof comprising administering to the patient a therapeutically effective amount of a NK-1 receptor antagonist and a pain medication.

Methods and dosage formulations for the safe treatment of cold, cough, flu, and sinus symptoms in children and adolescents by age and nature of symptoms, and adults and the elderly by age, nature of symptoms, and concomitant patient medical conditions. The method of the present invention comprises the formulation of a cold medication which consists essentially of combinations of a nonsedating or minimally sedating antihistamines with pain relievers and the expectorant, guaifenesin.

The invention relates to a plaster for improving facial nerve paralysis and a preparation method thereof, which comprises main ingredients and auxiliary materials. According to the weight ratio, the main ingredients are processed 30-40 parts of Schizonepetae, 30-40 parts of Fangfeng, and 50-60 parts of Chuanxiong , 50-60 parts of angelica, 50-60 parts of raw rehmannia, 40-50 parts of rehmannia glutinosa, 30-40 parts of Atractylodes macrocephala, 60-70 parts of Angelica dahurica, 60-70 parts of notopterygium, 60-70 parts of lovage, 20-30 parts of licorice , 40‑50 parts Poria cocos, 40‑50 parts Codonopsis pilosula, 50‑60 parts Astragalus membranaceus, 40‑50 parts safflower, 30‑40 parts blood remaining charcoal, 40‑50 parts rhubarb, 40‑50 parts ephedra, 10‑15 parts Asarum, 15-20 parts of castor beans, 30-40 parts of centipede, 25-30 parts of scorpion, 10-20 parts of borneol and 5-15 parts of nuxe; Composed of 2 times the amount of Huang Dan. The plaster of the present invention has a rapid effect on facial paralysis caused by various reasons. It can be obviously relieved after 1-3 days of application, and can be cured after 1-2 weeks of application. The effect is remarkable and rapid, and it is suitable for patients of all ages. The traditional Chinese medicine prescription is made into a plaster, which is convenient to use, safe and reliable, economical and convenient, and relieves the pain of taking the medicine.

The invention discloses a pharmaceutical composition for regulating menstruation and relieving pain, and a preparation method, a preparation and an application thereof. The pharmaceutical compositionfor regulating menstruation and relieving pain comprises 10 to 30 parts of bupleurum root in parts by weight of raw materials, 10 to 30 part of angelica, 10-30 part of radix paeoniae alba, 10-30 partsof rhizoma ligustici chuanxiong, 10-30 part of rhizoma cyperi preparata, 10-30 parts of radix codonopsis pilosulae, 10-30 parts of atractylodes macrocephala, 10-30 parts of tuckahoe, 10-30 part of peach kernel, 10-30 parts of salvia miltiorrhiza, 10-30 parts of rhizoma corydalis prepared with vinegar, 10-30 parts of pollen Typhae, 10-30 parts of mint, 10-30 parts of liquorice and 10-30 parts of ginger. The preparation comprises decoction, ointment, tablet, powder, capsule, granule and pill prepared by adding pharmaceutically acceptable adjuvant into the pharmaceutical composition for regulating menstruation and relieving pain. The pharmaceutical composition used for regulating menstruation and relieving pain is used for preparing menstruation regulating and relieving pain medicines. As the medicine of the invention are combined and synergistically effect, menstruation regulating and pain relieving effects are achieve.